Anesthesia devices includes monitors, continuous-flow anesthetic machines, anesthetics vaporizers, anesthesia information management system (AIMS), and other disposables such as anesthesia breathing circuits, endotracheal tubes, anesthesia gas masks, and laryngeal mask airway. Anesthesia machines are used to administer anesthesia in patients during surgery. These machines deliver variable gas mixtures, which are then delivered to the breathing systems for administering gases to patients using oxygen mask. Patients are administered a mixture of oxygen, nitrous oxide, and other gases that are regulated by anesthetic machines.
Global Anesthesia Devices Market– Impact of Coronavirus (COVID-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.The sudden outbreak of COVID-19 has bought the world to a standstill. The whole world is fighting this pandemic with increased burden on hospitals and healthcare professionals.
For instance, in May 2020, National Center for Biotechnology Information published a report on Impact of the Coronavirus (COVID-19) pandemic on surgical practice - (surgical prioritisation), which reported that Due to COVID-19, all surgical specialties had to limit their surgical practices and rationalize the surgeries which are performed. All surgery specialists have been asked to limit their follow up to telephone and video where possible. All surgery specialists have been asked to limit their follow up to telephone and video where possible.
Moreover, in April 2021, American Society of Plastic Surgeons published a report which stated that the society's board-certified plastic surgeons reported they stopped performing elective surgical procedures for an average of 8.1 weeks in 2020 due to COVID-19, or 15 percent of the year, which mirrors the decline in the total number of procedures performed in 2019. Whereas, American Society of Plastic Surgeons (ASPS) saw an overall 15% decrease in total number of cosmetic procedures in 2020 due to the COVID-19 pandemic in the U.S.
Global anesthesia devices market size was valued at US$ 14,977.9 million in 2022 and is expected to witness a CAGR of 7.6% over the forecast period (2022 – 2030).
Report Coverage | Details | ||
---|---|---|---|
Base Year: | 2021 | Market Size in 2022: | US$ 14,977.9 Mn |
Historical Data for: | 2017 to 2020 | Forecast Period: | 2022 to 2030 |
Forecast Period 2022 to 2030 CAGR: | 7.6% | 2030 Value Projection: | US$ 26,903.7 Mn |
Geographies covered: |
|
||
Segments covered: |
|
||
Companies covered: |
GE Healthcare, Spacelabs Healthcare., Septodont Inc, Draegerwerk AG & Co. KGaA, Beijing Aeonmed Co., Ltd., HEYER Medical AG, ORICARE, Inc., Philips Healthcare, Becton Dickinson and Company, Getinge AB., 3M, General Electric, SunMed, Teleflex Incorporated and Ambu A/S. |
||
Growth Drivers: |
|
||
Restraints & Challenges: |
|
Figure 1. Global Anesthesia Devices Market Share (%), by Product Type, 2022
Increasing organic strategies such as partnership by the market player is expected to drive the global anesthesia devices market growth over the forecast period.
Increasing organic strategies by the market player such as partnership is expected to drive the growth of global anesthesia device market over the forecast period. For instance, in November 2021, Zimbis, a provider of medication and supply management technology, announced a partnership with Southern Anesthesia & Surgical, Inc. (SAS), a U.S. distributor of anesthesia and surgical supplies to oral surgeons, dental anesthesiologists, and periodontists. The partnership with SAS supports Zimbis' mission to provide clients with solutions and workflows that address their specific medication and supply requirements. This announcement accompanies the launch of an order integration with SAS that streamlines the complicated and onerous process oral surgeons and other dental specialists typically need to take to order and restock inventory.
Global Anesthesia Devices Market: Restraints
Increasing product recall due to serious injuries or death is one of the major factor restraining the growth of global anesthesia market over the forecast. For instance, in September 2021, Armstrong Medical Limited, a manufacturer of hospital equipment, recalls AMSORB PLUS PREFILLED G-CAN 1.0L(AMSORB PLUS is a chemical substance used in anesthesia machines to absorb carbon dioxide (CO2) the patient breathes out while under anesthesia. This substance is provided in a prefilled canister (Prefilled G-CAN 1.0L) that is attached to the ventilator/anesthesia machine.) due to reduced gas flow to patients during anesthesia. The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. The difficulties in flow may cause a failure in the pre-use or “CHECK-OUT” test on the anesthesia machine. It may also occur when a patient is already under anesthesia if an affected canister is attached to the anesthesia machine while a patient is already under anesthesia.
Global Anesthesia Device Market – Region Analysis
On the basis of region, global disposable gloves market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East and Africa.
Increasing awareness among healthcare providers and surgeons is expected to boost the global anesthesia devices market growth
Manufacturers and healthcare organization in this region are focused on spreading awareness among healthcare providers and surgeons about anesthesia devices used in various surgical procedures. For instance, in May 2018, the American Society of Anesthesiologists (ASA) and CAE Healthcare, a healthcare company, launched interactive, screen-based simulation training product line Anesthesia SimSTAT. Anesthesia SimSTAT – Appendectomy training is designed to offer physician anesthesiologists to manage challenging anesthetic emergencies in patients undergoing laparoscopic surgeries for acute appendicitis. Anesthesia SimSTAT monitors and records the learner’s performance during the training and offers feedback after completion of a session.
Figure 2. Global Anesthesia Devices Market Share (%), by Region, 2022
Global Anesthesia Devices Market: Key Developments
Global Anesthesia Device Market – Competitive Landscape
Key players operating in the global anesthesia devices market include GE Healthcare, Spacelabs Healthcare., Septodont Inc, Draegerwerk AG & Co. KGaA, Beijing Aeonmed Co., Ltd., HEYER Medical AG, ORICARE, Inc., Philips Healthcare, Becton Dickinson and Company, Getinge AB., 3M, General Electric, SunMed, Teleflex Incorporated and Ambu A/S.
Anesthesia device is a medical tool that is used by surgeon to induce and maintain anesthesia during a patient’s surgery. The device is mainly used to mix anesthetic gases and vapors. During surgery, anesthesia devices are used to control pain, breathing, blood pressure, blood flow, and heart rate and rhythm. Anesthesia devices includes monitors, continuous-flow anesthetic machine, anesthetics vaporizers, anesthesia information management system (AIMS), ventilators, catheters, breathing systems, airways. Anesthesia devices are divided into respiratory devices and vascular access devices.
Market Dynamics
Anesthesia devices are used commonly in all types of surgeries as they are designed to offer an accurate and continuous supply of mixed medical gases with aesthetic vapors, which are delivered to patient at a safe pressure and flow. Increasing number of patients suffering from respiratory diseases is expected to boost growth of the market. According to the reports published by the World Health Organization, on May 20, 2022, Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. Whereas 90% of COPD deaths in those under 70 years of age occur in low- and middle-income countries (LMIC) such as India and Bangladesh.
Furthermore, according to the same source, on May 11, 2022, Asthma affected an estimated 262 million people in 2019 and caused 455 000 deaths globally. Most asthma-related deaths occur in low- and lower-middle-income countries such as India and Bangladesh, where under-diagnosis and under-treatment is a challenge.
Increasing product approval from the U.S. FDA (Food and Drug Administration) by key market player is expected to boost the market growth over the forecast period. For instance, on April 4, 2022, GE Healthcare, a multinational company, announced the FDA pre-market approval (PMA) for its End-tidal (Et) Control software for general anesthesia delivery on its Aisys CS2 Anesthesia Delivery System. The company initially released the technology in Europe in 2010 and according to the latest announcement anesthesia providers use Et Control software to care for patients in over 100 countries. The Et Control software semi-automates the delivery of anesthesia using software, allowing anesthesia providers to set targets for end-tidal oxygen and anesthetic agent. Once targets are set, the software quickly achieves and maintains those targets, regardless of changes in the patient's hemodynamic and metabolic status. The Et Control software improves anesthesia delivery accuracy and simplifies workflows while reducing drug waste, lowering the cost of care and greenhouse gas emissions.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients